首页 | 本学科首页   官方微博 | 高级检索  
检索        


Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysate
Authors:Mandana Haack-Sørensen  Morten Juhl  Bjarke Follin  Rebekka Harary Søndergaard  Maria Kirchhoff  Jens Kastrup
Institution:1. Cardiology Stem Cell Centre, The Heart Centre, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark;2. Department of Clinical Genetics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark
Abstract:In vitro expanded adipose-derived stromal cells (ASCs) are a useful resource for tissue regeneration. Translation of small-scale autologous cell production into a large-scale, allogeneic production process for clinical applications necessitates well-chosen raw materials and cell culture platform. We compare the use of clinical-grade human platelet lysate (hPL) and fetal bovine serum (FBS) as growth supplements for ASC expansion in the automated, closed hollow fibre quantum cell expansion system (bioreactor). Stromal vascular fractions were isolated from human subcutaneous abdominal fat. In average, 95?×?106 cells were suspended in 10% FBS or 5% hPL medium, and loaded into a bioreactor coated with cryoprecipitate. ASCs (P0) were harvested, and 30?×?106 ASCs were reloaded for continued expansion (P1). Feeding rate and time of harvest was guided by metabolic monitoring. Viability, sterility, purity, differentiation capacity, and genomic stability of ASCs P1 were determined. Cultivation of SVF in hPL medium for in average nine days, yielded 546?×?106 ASCs compared to 111?×?106 ASCs, after 17?days in FBS medium. ASCs P1 yields were in average 605?×?106 ASCs (PD population doublings]: 4.65) after six days in hPL medium, compared to 119?×?106 ASCs (PD: 2.45) in FBS medium, after 21?days. ASCs fulfilled ISCT criteria and demonstrated genomic stability and sterility. The use of hPL as a growth supplement for ASCs expansion in the quantum cell expansion system provides an efficient expansion process compared to the use of FBS, while maintaining cell quality appropriate for clinical use. The described process is an obvious choice for manufacturing of large-scale allogeneic ASC products.
Keywords:Adipose-derived stromal cells  bioreactor  clinical application  closed cultivation systems  cryoprecipitate  human platelet lysate  mesenchymal stromal cells  stem cells
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号